RemeGen Co

RemeGen Co OCF Margin

The Operating Cash Flow Margin of RemeGen Co (688331.SS) as of Oct 26, 2026 is 1.73 %. In the previous year, Operating Cash Flow Margin was -68.53 % — a change of -102.52% (higher).

OCF Margin

1.73 %

YoY

-102.52%

Last updated:

Operating Cash Flow Margin of RemeGen Co is 2025 1.73 % . Operating Cash Flow Margin of RemeGen Co was 2024 -68.53 % . It decreases by -102.52% higher compared to the previous year.

The RemeGen Co OCF Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

OCF Margin
Date
OCF Margin
Jan 1, 2018
-1,130.89 CNY
Jan 1, 2019
-10,545.11 CNY
Jan 1, 2020
135,902.20 CNY
Jan 1, 2021
18.51 CNY
Jan 1, 2022
-163.67 CNY
Jan 1, 2023
-138.68 CNY
Jan 1, 2024
-68.53 CNY
Jan 1, 2025
1.73 CNY
The RemeGen Co OCF Margin history
YEAROCF MarginYoY
1.73 %-102.52%
-68.53 %-50.58%
-138.68 %-15.27%
-163.67 %-983.99%
18.51 %-99.99%
135,902.20 %-1,388.77%
-10,545.11 %+832.46%
-1,130.89 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

RemeGen Co Stock analysis

What does RemeGen Co do? RemeGen Co Ltd generates revenue by researching, developing, and manufacturing innovative biopharmaceuticals, specifically focusing on therapeutic antibody drugs. The company's product portfolio includes tetacept (RC18), veldicitumab (RC48), and a dual-target fusion protein (RC28). These products are designed to treat major diseases such as oncology, autoimmune diseases, and ophthalmology. The firm operates primarily in the domestic market within China, where it commercializes its discoveries. Its business model relies on the development of various antibody types, including antibody drug conjugates (ADCs), antibody fusion proteins, monoclonal antibodies, and bispecific antibodies. This focus allows the company to address significant medical needs through its specialized therapeutic offerings. RemeGen Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about RemeGen Co stock

Operating Cash Flow Margin of RemeGen Co is 1.73 % in 2025.

Operating Cash Flow Margin of RemeGen Co changed from -68.53 % to 1.73 %, representing a -102.52% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Operating Cash Flow Margin RemeGen Co since 2006 – with annual values, charts, and detailed analysis.

OCF margin measures the percentage of revenue converted into operating cash flow. It indicates cash generation efficiency from core business operations.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Operating Cash Flow Margin's RemeGen Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Operating Cash Flow Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Operating Cash Flow Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — RemeGen Co

All Key Metrics — RemeGen Co